SINOPHARM
VACCINE
China National Biotec Group Company Limited (referred to as Sinopharm CNBG), a subsidiary of China National Pharmaceutical Group Co., Ltd. Sinopharm CNBG was the 6th vaccine to be authorized by the World Health Organization (WHO) for its emergency listing, receiving WHO validation for safety, efficacy and quality. It is produced by the Beijing Bio-Institute of Biological Products Co Ltd (BIBP), a subsidiary of Sinopharm CNBG.
| Product Name: |
| SARS-CoV-2 Vaccine (Vero Cell), Inactivated, or COVID-19 Vaccine (Vero Cell), Inactivated |
As an authorized partner, we assisted Duopharma Group and Lippo Group in the procurement of Sinopharm COVID-19 vaccines in Malaysia, Singapore and Myanmar.
WHO - Sinopharm COVID-19 vaccine: What you need to know - 7 May 2021
